Project Grant R01NS140141
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to prepare for a clinical trial to improve equitable access to neurology care and novel Alzheimer's disease and related dementias (ADRD) therapies for Black and Hispanic older adults. The $2,221,917 award to the University of California, Los Angeles (UCLA) will support research to...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $742,352 to New York University School of Medicine to conduct the "Childhood Adversity Research Effort in Multiple Sclerosis (CARE.IN.MS)" study. The goal of this multi-year research project is to collaboratively develop and execute a comprehensive, culturally-informed...
- This $198,928 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant will support research at the University of California, San Francisco to elucidate the cellular mechanisms underlying central nervous system injury and progression in multiple sclerosis. Key objectives include determining the role of astrocyte response,...
- This $2,291,595 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a longitudinal study to determine whether Epstein-Barr virus (EBV)-induced molecular mimicry is a likely cause of multiple sclerosis (MS) in African Americans. The award will fund a study using blood samples collected from over 10 million active duty U.S. military personnel to investigate the relationship...
- This federal Project Grant award of $654,287.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The goal of the project is to develop a computational model of neurocognitive impairment in multiple sclerosis (MS), focusing on updating the outdated framework used to characterize cognition in MS. The project aims to leverage cognitive psychology and...
- This Project Grant award in the amount of $521,839.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research at the University of California, San Diego to investigate the molecular mechanisms underlying the activation of microglia, which contribute to oxidative stress and tissue damage in multiple sclerosis (MS)....
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $231,000 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Rochester. The grant, which runs from March 1, 2025 to January 31, 2028, aims to develop culturally-tailored approaches to improve equity in palliative care research and service delivery for individuals with Parkinson's disease, Lewy body dementia, and related disorders living...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on generating socially- and culturally-aligned approaches to successfully engage Black communities in Southern California in brain health research and build a Black aging cohort. The $235,795 award will be used to: 1) identify and engage stakeholders in Los Angeles and Orange...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,234,191 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Board of Regents of the Nevada System of Higher Education, doing business as the University of Nevada, Las Vegas (UNLV). The grant, awarded on August 15, 2025, aims to identify barriers and facilitators to Alzheimer's disease and related dementia (AD/ADRD) clinical trial participation...
- This federal Project Grant award, titled "ADRD Risk and Resilience Among Black Americans: A 20-Year Longitudinal Study", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) for $3,177,045 from February 1, 2025 to January 31, 2030. The award aims to examine psychosocial risk and protective factors for cognitive functioning among middle-aged and older Black Americans using the National Survey of American Life (NSAL), a nationally representative sample. The first...
This Project Grant award of $657,841 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports a retrospective cohort study of 2,300 newly diagnosed individuals with relapsing multiple sclerosis (MS), including 450 Black and 600 Hispanic participants. The study aims to determine if differences in the timing and type of disease-modifying therapies prescribed, as well as levels of a biomarker (serum neurofilament light chain) indicating neuroaxonal damage at diagnosis, contribute to the higher rates of disability observed in Black and Hispanic MS patients compared to White patients. The award was made on August 4, 2025 with an ultimate completion date of July 31, 2030. The study will be conducted by the Kaiser Foundation Research Institute at the Kaiser Permanente Southern California healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $657.8k | 8/1/25 |